This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Amanatullah DF, Tamaresis JS, Chu P, Bachmann MH, Hoang NM, Collyar D, Mayer AT, West RB, Maloney WJ, Contag CH, et al. Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells. Breast Cancer Res. 2017 Dec;19(1):121. https://doi.org/10.1186/s13058-017-0910-xAmanatullahDFTamaresisJSChuPBachmannMHHoangNMCollyarDMayerATWestRBMaloneyWJContagCHet alLocal estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells2017Dec19112110.1186/s13058-017-0910-x568876129141657Open DOISearch in Google Scholar
Arroyo R, Martín V, Maldonado A, Jiménez E, Fernández L, Rodríguez JM. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of lactobacilli isolated from breast milk. Clin Infect Dis. 2010 Jun 15;50(12):1551–1558. https://doi.org/10.1086/652763ArroyoRMartínVMaldonadoAJiménezEFernándezLRodríguezJMTreatment of infectious mastitis during lactation: antibiotics versus oral administration of lactobacilli isolated from breast milk2010Jun 1550121551155810.1086/65276320455694Open DOISearch in Google Scholar
Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012 Oct 05;338(6103):120–123. https://doi.org/10.1126/science.1224820ArthurJCPerez-ChanonaEMühlbauerMTomkovichSUronisJMFanTJCampbellBJAbujamelTDoganBRogersABet alIntestinal inflammation targets cancer-inducing activity of the microbiota2012Oct 05338610312012310.1126/science.1224820364530222903521Open DOISearch in Google Scholar
Banerjee S, Tian T, Wei Z, Shih N, Feldman MD, Peck KN, DeMichele AM, Alwine JC, Robertson ES. Distinct microbial signatures associated with different breast cancer types. Front Micro-biol. 2018 May 15;9:951. https://doi.org/10.3389/fmicb.2018.00951BanerjeeSTianTWeiZShihNFeldmanMDPeckKNDeMicheleAMAlwineJCRobertsonESDistinct microbial signatures associated with different breast cancer types2018May 15995110.3389/fmicb.2018.00951596270629867857Open DOISearch in Google Scholar
Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014 Mar;157(1):121–141. https://doi.org/10.1016/j.cell.2014.03.011BelkaidYHandTWRole of the microbiota in immunity and inflammation2014Mar157112114110.1016/j.cell.2014.03.011405676524679531Open DOISearch in Google Scholar
Bobin-Dubigeon C, Luu HT, Leuillet S, Lavergne SN, Carton T, Le Vacon F, Michel C, Nazih H, Bard JM. Faecal microbiota composition varies between patients with breast cancer and healthy women: a comparative case-control study. Nutrients. 2021 Aug 05; 13(8):2705. https://doi.org/10.3390/nu13082705Bobin-DubigeonCLuuHTLeuilletSLavergneSNCartonTLeVacon FMichelCNazihHBardJMFaecal microbiota composition varies between patients with breast cancer and healthy women: a comparative case-control study2021Aug 05138270510.3390/nu13082705839970034444865Open DOISearch in Google Scholar
Bouchard DS, Seridan B, Saraoui T, Rault L, Germon P, Gonzalez-Moreno C, Nader-Macias FME, Baud D, François P, Chuat V, et al. Lactic acid bacteria isolated from bovine mammary microbiota: potential allies against bovine mastitis. PLoS One. 2015 Dec 29;10(12):e0144831. https://doi.org/10.1371/journal.pone.0144831BouchardDSSeridanBSaraouiTRaultLGermonPGonzalez-MorenoCNader-MaciasFMEBaudDFrançoisPChuatVet alLactic acid bacteria isolated from bovine mammary microbiota: potential allies against bovine mastitis2015Dec 291012e014483110.1371/journal.pone.0144831469470526713450Open DOISearch in Google Scholar
Braden A, Stankowski R, Engel J, Onitilo A. Breast cancer bio-markers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence. Curr Pharm Des. 2014 Aug 31;20(30):4879–4898. https://doi.org/10.2174/1381612819666131125145517BradenAStankowskiREngelJOnitiloABreast cancer bio-markers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence2014Aug 3120304879489810.2174/138161281966613112514551724283956Open DOISearch in Google Scholar
Bullerdiek J, Rommel B. Factors targeting MED12 to drive tumorigenesis? F 1000 Res. 2018;7:359. https://doi.org/10.12688/f1000research.14227.2BullerdiekJRommelBFactors targeting MED12 to drive tumorigenesis?1000Res. 2018735910.12688/f1000research.14227.2632561830647905Open DOISearch in Google Scholar
Claesson MJ, Jeffery IB, Conde S, Power SE, O’Connor EM, Cusack S, Harris HMB, Coakley M, Lakshminarayanan B, O’Sullivan O, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012 Aug;488(7410):178–184. https://doi.org/10.1038/nature11319ClaessonMJJefferyIBCondeSPowerSEO’ConnorEMCusackSHarrisHMBCoakleyMLakshminarayananBO’SullivanOet alGut microbiota composition correlates with diet and health in the elderly2012Aug488741017818410.1038/nature1131922797518Open DOISearch in Google Scholar
Di Modica M, Gargari G, Regondi V, Bonizzi A, Arioli S, Belmonte B, De Cecco L, Fasano E, Bianchi F, Bertolotti A, et al. Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer. Cancer Res. 2021 Apr 15;81(8): 2195–2206. https://doi.org/10.1158/0008-5472.CAN-20-1659DiModica MGargariGRegondiVBonizziAArioliSBelmonteBDe CeccoLFasanoEBianchiFBertolottiAet alGut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer2021Apr 158182195220610.1158/0008-5472.CAN-20-165933483370Open DOISearch in Google Scholar
Dzutsev A, Badger JH, Perez-Chanona E, Roy S, Salcedo R, Smith CK, Trinchieri G. Microbes and cancer. Annu Rev Immunol. 2017 Apr 26;35(1):199–228. https://doi.org/10.1146/annurev-immunol-051116-052133DzutsevABadgerJHPerez-ChanonaERoySSalcedoRSmithCKTrinchieriGMicrobes and cancer2017Apr 2635119922810.1146/annurev-immunol-051116-05213328142322Open DOISearch in Google Scholar
Eslami-SZ, Majidzadeh-AK, Halvaei S, Babapirali F, Esmaeili R. Microbiome and breast cancer: new role for an ancient population. Front Oncol. 2020 Feb 12;10:120. https://doi.org/10.3389/fonc.2020.00120Eslami-SZMajidzadeh-AKHalvaeiSBabapiraliFEsmaeiliRMicrobiome and breast cancer: new role for an ancient population2020Feb 121012010.3389/fonc.2020.00120702870132117767Open DOISearch in Google Scholar
Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, Costa JL, Carneiro F, Machado JC, Figueiredo C. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018 Feb;67(2):226–236. https://doi.org/10.1136/gutjnl-2017-314205FerreiraRMPereira-MarquesJPinto-RibeiroICostaJLCarneiroFMachadoJCFigueiredoCGastric microbial community profiling reveals a dysbiotic cancer-associated microbiota2018Feb67222623610.1136/gutjnl-2017-314205586829329102920Open DOISearch in Google Scholar
Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, Gajer P, Ravel J, Goedert JJ. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med. 2012 Dec;10(1):253. https://doi.org/10.1186/1479-5876-10-253FloresRShiJFuhrmanBXuXVeenstraTDGailMHGajerPRavelJGoedertJJFecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study2012Dec10125310.1186/1479-5876-10-253355282523259758Open DOISearch in Google Scholar
García Rodríguez LA, González-Pérez A. Use of antibiotics and risk of breast cancer. Am J Epidemiol. 2005 Apr 01;161(7):616–619. https://doi.org/10.1093/aje/kwi087GarcíaRodríguez LAGonzález-PérezAUse of antibiotics and risk of breast cancer2005Apr 01161761661910.1093/aje/kwi08715781950Open DOISearch in Google Scholar
Goedert JJ, Hua X, Bielecka A, Okayasu I, Milne GL, Jones GS, Fujiwara M, Sinha R, Wan Y, Xu X, et al. Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-non-coated faecal microbiota. Br J Cancer. 2018 Feb 20;118(4):471–479. https://doi.org/10.1038/bjc.2017.435GoedertJJHuaXBieleckaAOkayasuIMilneGLJonesGSFujiwaraMSinhaRWanYXuXet alPostmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-non-coated faecal microbiota2018Feb 20118447147910.1038/bjc.2017.435583059329360814Open DOISearch in Google Scholar
Goedert JJ, Jones G, Hua X, Xu X, Yu G, Flores R, Falk RT, Gail MH, Shi J, Ravel J, et al. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. JNCI: J Natl Cancer Inst. 2015 Aug;107(8):djv147. https://doi.org/10.1093/jnci/djv147GoedertJJJonesGHuaXXuXYuGFloresRFalkRTGailMHShiJRavelJet alInvestigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study2015Aug1078djv14710.1093/jnci/djv147455419126032724Open DOISearch in Google Scholar
Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018 Jan 05;359(6371):97–103. https://doi.org/10.1126/science.aan4236GopalakrishnanVSpencerCNNeziLReubenAAndrewsMCKarpinetsTVPrietoPAVicenteDHoffmanKWeiSCet alGut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients2018Jan 0535963719710310.1126/science.aan4236582796629097493Open DOISearch in Google Scholar
Goubet AG, Wheeler R, Fluckiger A, Qu B, Lemaître F, Iribarren K, Mondragón L, Tidjani Alou M, Pizzato E, Durand S, et al. Multifaceted modes of action of the anticancer probiotic Enterococcus hirae. Cell Death Differ. 2021 Jul;28(7):2276–2295. https://doi.org/10.1038/s41418-021-00753-8GoubetAGWheelerRFluckigerAQuBLemaîtreFIribarrenKMondragónLTidjaniAlou MPizzatoEDurandSet alMultifaceted modes of action of the anticancer probiotic Enterococcus hirae2021Jul2872276229510.1038/s41418-021-00753-8825778033976389Open DOISearch in Google Scholar
Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005 Jul 21;353(3):229–237. https://doi.org/10.1056/NEJMoa044383HartmannLCSellersTAFrostMHLingleWLDegnimACGhoshKVierkantRAMaloneySDPankratzVSHillmanDWet alBenign breast disease and the risk of breast cancer2005Jul 21353322923710.1056/NEJMoa04438316034008Open DOISearch in Google Scholar
Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, Xiao J, Radisky DC, Knutson KL, Kalari KR, et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep. 2016 Nov;6(1):30751. https://doi.org/10.1038/srep30751HiekenTJChenJHoskinTLWalther-AntonioMJohnsonSRamakerSXiaoJRadiskyDCKnutsonKLKalariKRet alThe microbiome of aseptically collected human breast tissue in benign and malignant disease2016Nov613075110.1038/srep30751497151327485780Open DOISearch in Google Scholar
Ingman WV. The gut microbiome: a new player in breast cancer metastasis. Cancer Res. 2019 Jul 15;79(14):3539–3541. https://doi.org/10.1158/0008-5472.CAN-19-1698IngmanWVThe gut microbiome: a new player in breast cancer metastasis2019Jul 1579143539354110.1158/0008-5472.CAN-19-169831308136Open DOISearch in Google Scholar
Jiang Y, Fan L. The effect of Poria cocos ethanol extract on the intestinal barrier function and intestinal microbiota in mice with breast cancer. J Ethnopharmacol. 2021 Feb;266:113456. https://doi.org/10.1016/j.jep.2020.113456JiangYFanLThe effect of Poria cocos ethanol extract on the intestinal barrier function and intestinal microbiota in mice with breast cancer2021Feb26611345610.1016/j.jep.2020.11345633039631Open DOISearch in Google Scholar
Johansson A, Christakou AE, Iftimi A, Eriksson M, Tapia J, Skoog L, Benz CC, Rodriguez-Wallberg KA, Hall P, Czene K, et al. Characterization of benign breast diseases and association with age, hormonal factors, and family history of breast cancer among women in Sweden. JAMA Netw Open. 2021 Jun 01;4(6):e2114716. https://doi.org/10.1001/jamanetworkopen.2021.14716JohanssonAChristakouAEIftimiAErikssonMTapiaJSkoogLBenzCCRodriguez-WallbergKAHallPCzeneKet alCharacterization of benign breast diseases and association with age, hormonal factors, and family history of breast cancer among women in Sweden2021Jun 0146e211471610.1001/jamanetworkopen.2021.14716823370334170304Open DOISearch in Google Scholar
Katagiri S, Shiba T, Tohara H, Yamaguchi K, Hara K, Nakagawa K, Komatsu K, Watanabe K, Ohsugi Y, Maekawa S, et al. Re-initiation of oral food intake following enteral nutrition alters oral and gut microbiota communities. Front Cell Infect Microbiol. 2019 Dec 20; 9:434. https://doi.org/10.3389/fcimb.2019.00434KatagiriSShibaTToharaHYamaguchiKHaraKNakagawaKKomatsuKWatanabeKOhsugiYMaekawaSet alRe-initiation of oral food intake following enteral nutrition alters oral and gut microbiota communities2019Dec 20943410.3389/fcimb.2019.00434695143031956606Open DOISearch in Google Scholar
Kovács T, Mikó E, Ujlaki G, Yousef H, Csontos V, Uray K, Bai P. The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer. Cancer Metastasis Rev. 2021 Dec;40(4):1223–1249. https://doi.org/10.1007/s10555-021-10013-3KovácsTMikóEUjlakiGYousefHCsontosVUrayKBaiPThe involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer2021Dec4041223124910.1007/s10555-021-10013-3882538434967927Open DOISearch in Google Scholar
Kwa M, Plottel CS, Blaser MJ, Adams S. The intestinal microbiome and estrogen receptor-positive female breast cancer. J Natl Cancer Inst. 2016 Apr 22;108(8). https://doi.org/10.1093/jnci/djw029KwaMPlottelCSBlaserMJAdamsSThe intestinal microbiome and estrogen receptor-positive female breast cancer2016Apr 22108810.1093/jnci/djw029501794627107051Open DOISearch in Google Scholar
Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-Méndez I, Alba E, Queipo-Ortuño MI. Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment. Cancers (Basel). 2020 Aug 31;12(9):2465. https://doi.org/10.3390/cancers12092465Laborda-IllanesASanchez-AlcoholadoLDominguez-RecioMEJimenez-RodriguezBLavadoRComino-MéndezIAlbaEQueipo-OrtuñoMIBreast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment2020Aug 31129246510.3390/cancers12092465756553032878124Open DOISearch in Google Scholar
Lakritz JR, Poutahidis T, Levkovich T, Varian BJ, Ibrahim YM, Chatzigiagkos A, Mirabal S, Alm EJ, Erdman SE. Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice. Int J Cancer. 2014 Aug; 135(3):529–540. https://doi.org/10.1002/ijc.28702LakritzJRPoutahidisTLevkovichTVarianBJIbrahimYMChatzigiagkosAMirabalSAlmEJErdmanSEBeneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice2014Aug135352954010.1002/ijc.28702413143924382758Open DOISearch in Google Scholar
Lakritz JR, Poutahidis T, Mirabal S, Varian BJ, Levkovich T, Ibrahim YM, Ward JM, Teng EC, Fisher B, Parry N, et al. Gut bacteria require neutrophils to promote mammary tumorigenesis. Oncotarget. 2015 Apr 20;6(11):9387–9396. https://doi.org/10.18632/oncotarget.3328LakritzJRPoutahidisTMirabalSVarianBJLevkovichTIbrahimYMWardJMTengECFisherBParryNet alGut bacteria require neutrophils to promote mammary tumorigenesis2015Apr 206119387939610.18632/oncotarget.3328449622425831236Open DOISearch in Google Scholar
Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017 Aug; 151(4):363–374. https://doi.org/10.1111/imm.12760LarsenJMThe immune response to Prevotella bacteria in chronic inflammatory disease2017Aug151436337410.1111/imm.12760550643228542929Open DOISearch in Google Scholar
Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol. 2016 Mar;17(3):230–240. https://doi.org/10.1038/ni.3384LasryAZingerABen-NeriahYInflammatory networks underlying colorectal cancer2016Mar17323024010.1038/ni.338426882261Open DOISearch in Google Scholar
Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, et al.; MetaHIT consortium. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013 Aug 29;500(7464):541–546. https://doi.org/10.1038/nature12506Le ChatelierENielsenTQinJPriftiEHildebrandFFalonyGAlmeidaMArumugamMBattoJMKennedySet alMetaHIT consortium. Richness of human gut microbiome correlates with metabolic markers2013Aug 29500746454154610.1038/nature1250623985870Open DOISearch in Google Scholar
Margolis KL, Rodabough RJ, Thomson CA, Lopez AM, McTiernan A; Women’s Health Initiative Research Group. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med. 2007 Sep 24;167(17):1837–1844. https://doi.org/10.1001/archinte.167.17.1837MargolisKLRodaboughRJThomsonCALopezAMMcTiernanA; Women’s Health Initiative Research GroupProspective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women2007Sep 24167171837184410.1001/archinte.167.17.183717893304Open DOISearch in Google Scholar
Méndez Utz VE, Pérez Visñuk D, Perdigón G, de Moreno de LeBlanc A. Milk fermented by Lactobacillus casei CRL431 administered as an immune adjuvant in models of breast cancer and metastasis under chemotherapy. Appl Microbiol Biotechnol. 2021 Jan; 105(1):327–340. https://doi.org/10.1007/s00253-020-11007-xMéndezUtz VEPérezVisñuk DPerdigónGdeMoreno de LeBlanc AMilk fermented by Lactobacillus casei CRL431 administered as an immune adjuvant in models of breast cancer and metastasis under chemotherapy2021Jan105132734010.1007/s00253-020-11007-x33205285Open DOISearch in Google Scholar
Meng S, Chen B, Yang J, Wang J, Zhu D, Meng Q, Zhang L. Study of microbiomes in aseptically collected samples of human breast tissue using needle biopsy and the potential role of in situ tissue microbiomes for promoting malignancy. Front Oncol. 2018 Aug 17;8:318. https://doi.org/10.3389/fonc.2018.00318MengSChenBYangJWangJZhuDMengQZhangLStudy of microbiomes in aseptically collected samples of human breast tissue using needle biopsy and the potential role of in situ tissue microbiomes for promoting malignancy2018Aug 17831810.3389/fonc.2018.00318610783430175072Open DOISearch in Google Scholar
Newman TM, Vitolins MZ, Cook KL. From the table to the tumor: the role of mediterranean and western dietary patterns in shifting microbial-mediated signaling to impact breast cancer risk. Nutrients. 2019 Oct 24;11(11):2565. https://doi.org/10.3390/nu11112565NewmanTMVitolinsMZCookKLFrom the table to the tumor: the role of mediterranean and western dietary patterns in shifting microbial-mediated signaling to impact breast cancer risk2019Oct 241111256510.3390/nu11112565689345731652909Open DOISearch in Google Scholar
Patel SH, Vaidya YH, Patel RJ, Pandit RJ, Joshi CG, Kunjadiya AP. Culture independent assessment of human milk microbial community in lactational mastitis. Sci Rep. 2017 Dec;7(1):7804. https://doi.org/10.1038/s41598-017-08451-7PatelSHVaidyaYHPatelRJPanditRJJoshiCGKunjadiyaAPCulture independent assessment of human milk microbial community in lactational mastitis2017Dec71780410.1038/s41598-017-08451-7555281228798374Open DOISearch in Google Scholar
Pellegrini M, Ippolito M, Monge T, Violi R, Cappello P, Ferrocino I, Cocolin LS, De Francesco A, Bo S, Finocchiaro C. Gut microbiota composition after diet and probiotics in overweight breast cancer survivors: a randomized open-label pilot intervention trial. Nutrition. 2020 Jun;74:110749. https://doi.org/10.1016/j.nut.2020.110749PellegriniMIppolitoMMongeTVioliRCappelloPFerrocinoICocolinLSDeFrancesco ABoSFinocchiaroCGut microbiota composition after diet and probiotics in overweight breast cancer survivors: a randomized open-label pilot intervention trial2020Jun7411074910.1016/j.nut.2020.11074932234652Open DOISearch in Google Scholar
Pourbaferani M, Modiri S, Norouzy A, Maleki H, Heidari M, Alidoust L, Derakhshan V, Zahiri HS, Noghabi KA. A newly characterized potentially probiotic strain, Lactobacillus brevis MK05, and the toxicity effects of its secretory proteins against MCF-7 breast cancer cells. Probiotics Antimicrob Proteins. 2021 Aug;13(4):982–992. https://doi.org/10.1007/s12602-021-09766-8PourbaferaniMModiriSNorouzyAMalekiHHeidariMAlidoustLDerakhshanVZahiriHSNoghabiKAA newly characterized potentially probiotic strain, Lactobacillus brevis MK05, and the toxicity effects of its secretory proteins against MCF-7 breast cancer cells2021Aug13498299210.1007/s12602-021-09766-833687634Open DOISearch in Google Scholar
Rao VP, Poutahidis T, Fox JG, Erdman SE. Breast cancer: should gastrointestinal bacteria be on our radar screen? Cancer Res. 2007 Feb 01;67(3):847–850. https://doi.org/10.1158/0008-5472.CAN-06-3468RaoVPPoutahidisTFoxJGErdmanSEBreast cancer: should gastrointestinal bacteria be on our radar screen?2007Feb 0167384785010.1158/0008-5472.CAN-06-346817283110Open DOISearch in Google Scholar
Rutkowski MR, Stephen TL, Svoronos N, Allegrezza MJ, Tesone AJ, Perales-Puchalt A, Brencicova E, Escovar-Fadul X, Nguyen JM, Cadungog MG, et al. Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. Cancer Cell. 2015 Jan;27(1):27–40. https://doi.org/10.1016/j.ccell.2014.11.009RutkowskiMRStephenTLSvoronosNAllegrezzaMJTesoneAJPerales-PuchaltABrencicovaEEscovar-FadulXNguyenJMCadungogMGet alMicrobially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation2015Jan271274010.1016/j.ccell.2014.11.009429326925533336Open DOISearch in Google Scholar
Sergentanis TN, Zagouri F, Zografos GC. Is antibiotic use a risk factor for breast cancer? A meta-analysis. Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1101–1107. https://doi.org/10.1002/pds.1986SergentanisTNZagouriFZografosGCIs antibiotic use a risk factor for breast cancer? A meta-analysis2010Nov19111101110710.1002/pds.198620845408Open DOISearch in Google Scholar
Shi J, Geng C, Sang M, Gao W, Li S, Yang S, Li Z. Effect of gastrointestinal microbiome and its diversity on the expression of tumor-infiltrating lymphocytes in breast cancer. Oncol Lett. 2019 Jun;17(6):5050–5056. https://doi.org/10.3892/ol.2019.10187ShiJGengCSangMGaoWLiSYangSLiZEffect of gastrointestinal microbiome and its diversity on the expression of tumor-infiltrating lymphocytes in breast cancer2019Jun1765050505610.3892/ol.2019.10187650729831186716Open DOISearch in Google Scholar
Shimizu J, Kubota T, Takada E, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, Suzuki T, Suzuki N. Relative abundance of Megamonas hypermegale and Butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with Behcet’s disease (210 characters). Clin Rheumatol. 2019 May;38(5):1437–1445. https://doi.org/10.1007/s10067-018-04419-8ShimizuJKubotaTTakadaETakaiKFujiwaraNArimitsuNUedaYWakisakaSSuzukiTSuzukiNRelative abundance of Megamonas hypermegale and Butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with Behcet’s disease (210 characters)2019May3851437144510.1007/s10067-018-04419-830628011Open DOISearch in Google Scholar
Simin J, Tamimi RM, Engstrand L, Callens S, Brusselaers N. Antibiotic use and the risk of breast cancer: a systematic review and dose-response meta-analysis. Pharmacol Res. 2020 Oct;160:105072. https://doi.org/10.1016/j.phrs.2020.105072SiminJTamimiRMEngstrandLCallensSBrusselaersNAntibiotic use and the risk of breast cancer: a systematic review and dose-response meta-analysis2020Oct16010507210.1016/j.phrs.2020.10507232679181Open DOISearch in Google Scholar
Sørensen HT, Skriver MV, Friis S, McLaughlin JK, Blot WJ, Baron JA. Use of antibiotics and risk of breast cancer: a population-based case-control study. Br J Cancer. 2005 Feb;92(3):594–596. https://doi.org/10.1038/sj.bjc.6602313SørensenHTSkriverMVFriisSMcLaughlinJKBlotWJBaronJAUse of antibiotics and risk of breast cancer: a population-based case-control study2005Feb92359459610.1038/sj.bjc.6602313236207315611791Open DOISearch in Google Scholar
Terrisse S, Derosa L, Iebba V, Ghiringhelli F, Vaz-Luis I, Kroemer G, Fidelle M, Christodoulidis S, Segata N, Thomas AM, et al. Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment. Cell Death Differ. 2021 Sep; 28(9):2778–2796. https://doi.org/10.1038/s41418-021-00784-1TerrisseSDerosaLIebbaVGhiringhelliFVaz-LuisIKroemerGFidelleMChristodoulidisSSegataNThomasAMet alIntestinal microbiota influences clinical outcome and side effects of early breast cancer treatment2021Sep2892778279610.1038/s41418-021-00784-1840823033963313Open DOISearch in Google Scholar
Urbaniak C, Cummins J, Brackstone M, Macklaim JM, Gloor GB, Baban CK, Scott L, O’Hanlon DM, Burton JP, Francis KP, et al. Microbiota of human breast tissue. Appl Environ Microbiol. 2014 May 15;80(10):3007–3014. https://doi.org/10.1128/AEM.00242-14UrbaniakCCumminsJBrackstoneMMacklaimJMGloorGBBabanCKScottLO’HanlonDMBurtonJPFrancisKPet alMicrobiota of human breast tissue2014May 1580103007301410.1128/AEM.00242-14401890324610844Open DOISearch in Google Scholar
Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G. The microbiota of breast tissue and its association with breast cancer. Appl Environ Microbiol. 2016 Aug 15;82(16):5039–5048. https://doi.org/10.1128/AEM.01235-16UrbaniakCGloorGBBrackstoneMScottLTangneyMReidGThe microbiota of breast tissue and its association with breast cancer2016Aug 1582165039504810.1128/AEM.01235-16496854727342554Open DOISearch in Google Scholar
Warren RL, Freeman DJ, Pleasance S, Watson P, Moore RA, Cochrane K, Allen-Vercoe E, Holt RA. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome. 2013 Dec; 1(1):16. https://doi.org/10.1186/2049-2618-1-16WarrenRLFreemanDJPleasanceSWatsonPMooreRACochraneKAllen-VercoeEHoltRACo-occurrence of anaerobic bacteria in colorectal carcinomas2013Dec111610.1186/2049-2618-1-16397163124450771Open DOISearch in Google Scholar
Watts AM, West NP, Zhang P, Smith PK, Cripps AW, Cox AJ. The gut microbiome of adults with allergic rhinitis is characterised by reduced diversity and an altered abundance of key microbial taxa compared to controls. Int Arch Allergy Immunol. 2021;182(2):94–105. https://doi.org/10.1159/000510536WattsAMWestNPZhangPSmithPKCrippsAWCoxAJThe gut microbiome of adults with allergic rhinitis is characterised by reduced diversity and an altered abundance of key microbial taxa compared to controls202118229410510.1159/00051053632971520Open DOISearch in Google Scholar
Wirtz HS, Buist DSM, Gralow JR, Barlow WE, Gray S, Chubak J, Yu O, Bowles EJA, Fujii M, Boudreau DM. Frequent antibiotic use and second breast cancer events. Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1588–1599. https://doi.org/10.1158/1055-9965.EPI-13-0454WirtzHSBuistDSMGralowJRBarlowWEGraySChubakJYuOBowlesEJAFujiiMBoudreauDMFrequent antibiotic use and second breast cancer events2013Sep2291588159910.1158/1055-9965.EPI-13-0454376944223833124Open DOISearch in Google Scholar
Worsham MJ, Raju U, Lu M, Kapke A, Botttrell A, Cheng J, Shah V, Savera A, Wolman SR. Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat. 2009 Nov; 118(1):1–7. https://doi.org/10.1007/s10549-008-0198-8WorshamMJRajuULuMKapkeABotttrellAChengJShahVSaveraAWolmanSRRisk factors for breast cancer from benign breast disease in a diverse population2009Nov11811710.1007/s10549-008-0198-8371532218836828Open DOISearch in Google Scholar
Wu AH, Tseng C, Vigen C, Yu Y, Cozen W, Garcia AA, Spicer D. Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study. Breast Cancer Res Treat. 2020 Jul;182(2):451–463. https://doi.org/10.1007/s10549-020-05702-6WuAHTsengCVigenCYuYCozenWGarciaAASpicerDGut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study2020Jul182245146310.1007/s10549-020-05702-6729786932468338Open DOISearch in Google Scholar
Yang P, Wang Z, Peng Q, Lian W, Chen D. Comparison of the gut microbiota in patients with benign and malignant breast tumors: a pilot study. Evol Bioinform Online. 2021 Jan;17: 11769343211057573. https://doi.org/10.1177/11769343211057573YangPWangZPengQLianWChenDComparison of the gut microbiota in patients with benign and malignant breast tumors: a pilot study2021Jan171176934321105757310.1177/11769343211057573859328934795472Open DOISearch in Google Scholar
Zhu B, Wang X, Li L. Human gut microbiome: the second genome of human body. Protein Cell. 2010 Aug; 1(8):718–725. https://doi.org/10.1007/s13238-010-0093-zZhuBWangXLiLHuman gut microbiome: the second genome of human body2010Aug1871872510.1007/s13238-010-0093-z487519521203913Open DOISearch in Google Scholar
Zhu J, Liao M, Yao Z, Liang W, Li Q, Liu J, Yang H, Ji Y, Wei W, Tan A, et al. Breast cancer in postmenopausal women is associated with an altered gut metagenome. Microbiome. 2018 Dec;6(1):136. https://doi.org/10.1186/s40168-018-0515-3ZhuJLiaoMYaoZLiangWLiQLiuJYangHJiYWeiWTanAet alBreast cancer in postmenopausal women is associated with an altered gut metagenome2018Dec6113610.1186/s40168-018-0515-3608054030081953Open DOISearch in Google Scholar